Lymphomas/CLL

John M. Burke MD and Jeff P. Sharman MD review data from key lymphoma/CLL presentations at the 2016 American Society of Hematology Annual Meeting.

Share

Program Content

Activities

  • Ibrutinib Discontinuation
    Retrospective Analysis of Ibrutinib Discontinuation and Outcomes in CLL in Trial vs Real-World Settings
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 05, 2016

    Expires: December 04, 2017

  • REMARC: Lenalidomide Maintenance in DLBCL
    REMARC: Lenalidomide vs Placebo as Maintenance Therapy in Patients With DLBCL Following R-CHOP Induction
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 06, 2016

    Expires: December 05, 2017

  • LyMa Trial in MCL
    Phase III LyMa Trial: Post-ASCT Rituximab Maintenance Increases Survival for Younger Patients With Mantle Cell Lymphoma
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 06, 2016

    Expires: December 05, 2017

  • Brentuximab Vedotin for CTCL
    ALCANZA: Brentuximab Vedotin vs Methotrexate or Bexarotene in Patients With CD30-Positive Cutaneous T-Cell Lymphoma
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 06, 2016

    Expires: December 05, 2017

  • R-CHOP vs DA-EPOCH-R in DLBCL
    CALGB/Alliance 50303: R-CHOP vs DA-EPOCH-R in Newly Diagnosed Diffuse Large B-Cell Lymphoma
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 07, 2016

    Expires: December 06, 2017

  • Venetoclax in R/R CLL
    Venetoclax in Patients With CLL Relapsed/Refractory to Ibrutinib or Idelalisib
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 08, 2016

    Expires: December 07, 2017

  • Rituximab + LEN in FL
    Phase II SAKK 35/10 Trial: Rituximab Plus Lenalidomide Shows Durable Activity in Untreated Follicular Lymphoma
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 09, 2016

    Expires: December 08, 2017

  • BR vs FCR Long-term Outcomes
    CL110: Updated Analysis of First-line BR vs FCR in Fit Patients With Chronic Lymphocytic Leukemia
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 09, 2016

    Expires: December 08, 2017

  • GALLIUM: Obinutuzumab in FL
    GALLIUM: Obinutuzumab- vs Rituximab-Based Immunochemotherapy in Patients With Untreated Follicular Lymphoma
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 09, 2016

    Expires: December 08, 2017

  • CART in Refractory DLBCL
    Phase II ZUMA-1: Interim Analysis of Anti-CD19 CAR T-Cell Therapy in Patients With Refractory Aggressive DLBCL
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 09, 2016

    Expires: December 08, 2017

  • Pembrolizumab in R/R cHL
    KEYNOTE-087: Pembrolizumab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 12, 2016

    Expires: December 11, 2017

  • GP2013 in Follicular Lymphoma
    ASSIST-FL: Rituximab Biosimilar GP2013 vs Rituximab in Treatment-Naive Patients With Advanced Follicular Lymphoma
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 12, 2016

    Expires: December 11, 2017

  • Phase II: Ibrutinib in MZL
    Phase II PCYC-1121 Trial: Ibrutinib Monotherapy Active in R/R Marginal Zone Lymphoma
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 12, 2016

    Expires: December 11, 2017

  • Downloadable Slideset
    Lymphomas and CLL
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 05, 2017

    Expires: January 04, 2018

Provided by

ProCE Banner

Supporters

Amgen, Inc.

Celgene

Incyte

Merck & Co., Inc.

Seagen